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Lidase Treatment of Stinal 
A 
Cord Transected Rats 
Timothy F. Kowalski, BS, €3. Lee Vahlsing, MS, 
and Earl R. Feringa, MD 
Russian investigators have recently reported clinical 
recovery of enzyme treated, spinal cord transected rats. 
Using the exact protocols outlined by Matinian and 
Andreasian, we repeated a portion of their experiment 
using a Lidase preparation manufactured in the USSR. 
Animals were evaluated for return of bladder func- 
tion, clinical evidence of hind limb motor function, 
cortical evoked response after sciatic nerve stimula- 
tion, and axonal transport of cortically injected 
tritiated proline by regenerated corticospinal axons. 
The only difference between treated and control 
animals was that the mean total body weight of the 
treated animals increased more than that of controls ( p  
< 0.05). No animal walked, had return of voluntary 
motor activity, showed cortical evoked response, or 
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had evidence for transport of tritiated proline over re- 
generated corticospinal axons. 
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Russian investigators [3, 41 have reported that en- 
zyme treatment facilitates axonal regeneration and 
return of function in spinal cord transected rats. 
Matinian and Andreasian [ 3 ]  have stated that use of 
the enzyme preparation Lidase [ 11 is effective in en- 
hancing axonal regeneration and promoting func- 
tional return. In a previous experiment [2] using the 
exact protocols of Matinian and Andreasian’s two 
most successful enzyme treatment paradigms, we 
were unable to duplicate their results. However, 
since we used enzymes manufactured in the United 
States, it remained possible that an unknown factor 
contained in the Russian-produced enzymes could 
have been responsible for the reported regeneration. 
For this experiment we obtained Lidase prepared 
in the Soviet Union. Following Matinian and Andrea- 
sian’s protocol exactly, we sought to determine if this 
preparation was effective in enhancing axonal regen- 
eration in our laboratory. 
Materials and Methods 
Six-week-old albino isogeneic female rats, descended from 
Wistar stock, were used in the experiment. Each weighed 
approximately 125 gm. The surgical techniques utilized 
were identical to those described in our previous enzyme 
experiment [2]. 
Animals were treated either with Lidase, following the 
protocol of Matinian and Andreasian, or with the enzyme 
vehicle only. A stock solution of Lidase was prepared ac- 
cording to the package insert directions [ 5 ] .  One ampoule 
containing 64 U of dried enzyme powder was dissolved in 2 
ml of Novocain: a 0.5% sterile procaine hydrochloride so- 
lution with l mg of sodium hydrosulfite per milliliter and 
sodium chloride for isotonicity. The volume of solution 
required for the proper 32 U per kilogram dosage for each 
animal was further diluted with 0.9% saline so that each 
animal received an equal 0.5 ml injection subcutaneously 
over the site of spinal cord transection. Control animals 
received similar injections without enzyme. 
The procedures used for evaluating bladder function, 
clinical activity, electrophysiological response, and axonal 
flow of radioisotopic proline were identical to those de- 
scribed previously [2]. 
Results 
The interval between cordotomy and return of reflex 
bladder function was not significantly different be- 
tween treated and control animals (Table). NO 
significant differences in clinical variables were found 
when treated animals were compared to controls ex- 
cept that the treated animals weighed more than the 
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Return of Bladder Function 
No. 
of 
Group Days Mean 
This study 
Lidase (N = 14) 11-15 12.80 




Treated (N = 248) 6-16 Not reported 
Control (N = 94) 17-45 Not reported 
controls ( p  < 0.05). No significant changes in func- 
tion or physical condition occurred during the evalu- 
ation period within any of the groups except that 
muscle atrophy and mean total body weight both in- 
creased with time in each group. None of the animals 
walked. 
No animal in the experiment showed a cortical 
evoked response as measured by our method [2]. 
No significant differences were observed between 
treated and control groups in axoplasmic flow of 
tritiated proline by regenerated axons as determined 
by the mean value of the ratio of disintegrations per 
minute distally versus proximally (0.033 in the Lidase 
group, 0.037 in contro1s;P = 0.77). 
Discussion 
Many believe that mesenchymal and neuroglial scars, 
which form after central nervous system trauma, act 
as a barrier blocking the passage of regenerating 
axons through the site of injury. Matinian and An- 
dreasian believe collagenous scar is the type primarily 
responsible for blocking regenerating axon sprouts. 
To alter this barrier, they have utilized various 
fibrinolytic and proteolytic enzymes that break up 
the connective tissue components of scar. 
One of the enzymes Matinian and Andreasian used 
was Lidase. Lidase is reported to act specifically on 
the substrate hyaluronic acid [ 11. Hyaluronic acid is 
an acid mucopolysaccharide found in the extracellu- 
lar ground substance of connective tissue in verte- 
brates. As the concentration of hyaluronic acid in scar 
tissue increases, the scar tissue’s permeability de- 
creases. Lidase is reported to increase permeability 
by depolymerizing the hyaluronic acid found in scar 
tissue [31. 
Our results fail to confirm the beneficial effects of 
Lidase therapy on CNS regeneration reported by 
Matinian and Andreasian. They reported that treated 
animals, which later showed positive signs of regen- 
eration, regained bladder function earlier than con- 
trols. We found no difference. They reported that 
their Lidase-treated animals, which later showed 
positive signs of regeneration, gained weight faster 
than their respective controls. They also reported 
that 33.3% of their Lidase-treated animals showed 
“full recovery of function” and that 57.1% had at 
least “partial recovery of function.” We found no 
differences in clinical variables between treated and 
control animals except that treated animals weighed 
significantly more than controls (P < 0.05). Matinian 
and Andreasian reported that 53 of 59 treated ani- 
mals, compared to 0 of 11 controls, showed a cortical 
evoked response after stimulation of the sciatic 
nerve. Their 59 treated animals were selected from 
all eleven of their treatment groups, including one 
group treated with Lidase. None of our animals 
showed regeneration as measured by cortical evoked 
potential. Since no further breakdown of their results 
was reported, we cannot determine which treatment 
group included animals demonstrating cortical 
evoked response. We do know that Matinian and 
Andreasian tested 5 of 6 3  animals treated with 
Lidase. How they selected these animals for testing 
and the specific result for each treatment group were 
not reported. Finally, our radioisotopic evaluation 
showed no significant difference between treated and 
control animals. 
We cannot confirm that Lidase treatment enhances 
axonal regeneration. Our previous experiment 121 
failed to confirm the beneficial effects of trypsin- 
elastase or hyaluronidase-trypsin treatment combi- 
nations. The reason for the difference in results 
between our experiments and Matinian and An- 
dreasian’s remains unclear. Unique experimental ani- 
mals, incomplete spinal cord transections, or other, 
unknown factors may be responsible. 
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